Clinical Trials Directory

Trials / Conditions / AIDS-related Peripheral/Systemic Lymphoma

AIDS-related Peripheral/Systemic Lymphoma

13 registered clinical trials studyying AIDS-related Peripheral/Systemic Lymphoma.

StatusTrialSponsorPhase
CompletedIntravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-
NCT01775475
AIDS Malignancy ConsortiumPhase 2
WithdrawnGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgki
NCT01769911
Fred Hutchinson Cancer CenterN/A
CompletedRO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
NCT01158274
National Cancer Institute (NCI)Phase 1
TerminatedTanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas
NCT00096005
National Cancer Institute (NCI)Phase 1
CompletedCilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or Lymphoma
NCT00077155
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III,
NCT00049036
National Cancer Institute (NCI)Phase 2
TerminatedRadiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children Wit
NCT00036855
National Cancer Institute (NCI)Phase 1
CompletedBryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma
NCT00022555
National Cancer Institute (NCI)Phase 1
CompletedImatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
NCT00025415
National Cancer Institute (NCI)Phase 1
CompletedTopotecan Hydrochloride in Treating Children With Meningeal Cancer That Has Not Responded to Previous Treatmen
NCT00005811
National Cancer Institute (NCI)Phase 2
CompletedFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenola
NCT00112593
Fred Hutchinson Cancer CenterN/A
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymph
NCT00004241
National Cancer Institute (NCI)Phase 1
CompletedGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
NCT00003970
National Cancer Institute (NCI)Phase 1